News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Orbus Neich, Boston Scientific Corporation (BSX) Settle Patent Litigation



9/17/2013 7:52:56 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

OrbusNeich, Boston Scientific Settle Patent Litigation

LAUDERDALE, Fla.
and NATICK, Mass., Sept. 17, 2013 /PRNewswire/ -- OrbusNeich Medical Inc. and Boston Scientific Corporation (NYSE: BSX) have settled all stent-related litigation between the companies. The agreement resolves cases brought by the parties in Germany, the Netherlands, Ireland, the United Kingdom and the United States. The agreement, which includes a one-time payment from Boston Scientific to OrbusNeich, settles all stent-related disputes between the companies and does not include future financial obligations.

About OrbusNeich
OrbusNeich is a global company that designs, develops, manufactures and markets innovative medical devices for the treatment of vascular diseases. Current products are the world's first dual therapy stent, the COMBO Dual Therapy Stent, and the world's first pro-healing stent, the Genous Stent. Other products include stents and balloons marketed under the names of Azule, R stent, Scoreflex, Sapphire, Sapphire II and Sapphire NC. OrbusNeich is headquartered in Hong Kong and has operations in Shenzhen, China; Fort Lauderdale, Fla.; Hoevelaken, The Netherlands; and Tokyo, Japan. OrbusNeich supplies medical devices to interventional cardiologists in more than 60 countries. For more information, visit www.OrbusNeich.com.

About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 30 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.


CONTACTS:

OrbusNeich Medical:



Boston Scientific:

Jamie Moser / Bryan Darrow


Joele Frank, Wilkinson Brimmer Katcher

Peter Lucht

212-355-4449

Media Relations


508-650-8796


media@bsci.com




Michael Campbell


508-650-8023


Investor Relations


investor_relations@bsci.com


SOURCE OrbusNeich Medical Inc.; Boston Scientific Corporation



Help employers find you! Check out all the jobs and post your resume.
Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES